The expanded facility will enhance Singapore’s biopharmaceutical manufacturing capabilities, producing innovative treatments and offering high-skilled career opportunities.
SINGAPORE: Pfizer’s newly expanded Active Pharmaceutical Ingredient (API) manufacturing facility in Tuas Biomedical Park, with an investment of S$1 billion (US$743 million), was officially opened on Tuesday (Jul 23). The state-of-the-art extension is set to create more than 250 high-skilled jobs in areas such as production, quality, and engineering.
The facility will produce small molecule APIs for Pfizer’s oncology, pain, and antibiotic medicines, catering to global markets. This expansion underscores Pfizer’s commitment to advancing its manufacturing capabilities, incorporating the latest technologies such as modular and flexible production systems, and integrated smart factory solutions.
At the opening ceremony, Deputy Prime Minister and Minister for Trade and Industry Gan Kim Yong highlighted the significance of the facility in bolstering Singapore’s biopharmaceutical sector.
“This extension will strengthen Pfizer’s ability to produce life-saving drugs from its future R&D pipeline. It also creates over 250 highly skilled job opportunities, offering Singaporeans meaningful and rewarding careers,” said Mr. Gan.
Pfizer already employs around 400 workers at its existing facility in Singapore. The biopharmaceutical manufacturing sector has seen significant growth over the past two decades, with employment more than doubling to over 9,000 professionals.
Mr. Gan emphasized the government’s commitment to talent development in the sector, citing initiatives like the Industrial Post-graduate Programme and leadership development schemes.
“These efforts align with our goal to position Singapore as a global hub for companies to innovate, manufacture, and commercialize healthcare solutions,” he added.
The new facility represents a major milestone in Singapore’s journey to becoming a leader in biopharmaceutical manufacturing, combining cutting-edge technology with talent development to support the healthcare needs of tomorrow.
